BioPharma Resources

Drug Trial Radar · NCT05080959

A Phase 2, Randomized, Double-Blind, Dose Escalation Study in Postoperative Pain Open Inguinal Herniorrhaphy

A Randomized, Double-Blind, Placebo- and Active-Controlled, Dose Escalation and Optional Dose Expansion Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of CPL-01 in Postoperative Pain After Open Inguinal Herniorrhaphy

Last checked: Nov 19, 2026Latest source record: Jul 20, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 105 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

105

Actual

Start

Jul 28, 2021

Primary completion

Dec 31, 2021

Study completion Jun 10, 2022

Sponsor

Lead sponsor
Cali Pharmaceuticals LLCIndustry
Sponsor type
Industry
First posted
Oct 18, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 2b, randomized, double blind, placebo and active controlled study with an Ascending Dose Stage and an optional Dose Expansion Stage in subjects undergoing open inguinal herniorrhaphy with mesh.

Conditions

  • Inguinal Herniorrhaphy

Interventions

  • CPL-01Drug

    Subjects will receive a single dose

  • Naropin 150 MG Per 20 ML InjectionDrug

    Subjects will receive a single dose

  • PlaceboDrug

    Subjects will receive a single dose

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. AUC of the NRS-A for pain (Primary Endpoint)Time frame: 0 - 72 hours

Locations

5 sites in 1 country. Site status is shown where the registry gives one.

  • Shoals Medical Trials, Inc

    Sheffield, Alabama

  • Arizona Research Center

    Phoenix, Arizona

  • Anaheim Clinical Trials

    Anaheim, California

  • First Surgical Hospital

    Bellaire, Texas

  • Jean Brown Research

    Salt Lake City, Utah

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.